Phase 3 Results

AstraZeneca’s Sone-Ve Delivers Phase III Survival Breakthrough

CAMBRIDGE, UK, July 27, 2026 AstraZeneca has announced positive high-level results from the global Phase III CLARITY-Gastric01 trial, demonstrating...

By cGxPwire Editor
July 28, 2026

.Clinical

EMA Validates ENHERTU Combo for First-Line HER2 Breast Cancer

TOKYO and MUNICH | January 19, 2026 — Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency (EMA)...

By cGxPwire Editor
January 20, 2026

.Clinical

Nxera Reports Positive Phase 3 Results for Daridorexant

TOKYO, Japan and CAMBRIDGE, United Kingdom | January 19, 2026 — Nxera Pharma Co., Ltd. announced positive top-line results...

By cGxPwire Editor
January 20, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

AstraZeneca’s Sone-Ve Delivers Phase III Survival Breakthrough

EMA Validates ENHERTU Combo for First-Line HER2 Breast Cancer

Nxera Reports Positive Phase 3 Results for Daridorexant